MetaSystems Hard & Software GmbH

MetaSystems Hard & Software GmbH specializes in clinical management support software for in vitro diagnostics (IVD), particularly automated systems for microscopy-based imaging. Their key offerings include karyotyping cell-image analysers, which analyze cell images to identify chromosomal abnormalities, and other microscopy-based imaging tools designed to streamline laboratory workflows. These devices are developed to assist in diagnostic processes where precise image analysis is critical.

MetaSystems Hard & Software GmbH is based in Germany, which means its devices must comply with the European Union’s medical device regulations (MDR or IVDR, depending on the device type). Since they are listed in the EU’s EUDAMED database and the FDA’s UDI system, their products are designed to meet both European and U.S. regulatory requirements. The company’s German location also implies adherence to stringent EU standards for software and IVD devices, including risk classification and post-market surveillance.

MetaSystems Hard & Software GmbH’s devices fall under Class A, Class I, and Class II classifications under EU regulations. This classification determines the level of scrutiny and regulatory requirements for each device. For example, Class II devices—such as automated karyotyping systems—require more rigorous validation due to their higher risk potential, while Class A devices (e.g., certain software tools) have lower risk and fewer compliance hurdles. The classification ensures appropriate oversight while balancing innovation with patient safety.

MetaSystems Hard & Software GmbH’s devices are listed in EUDAMED (the European Union’s medical device database) and the FDA’s UDI system (Unique Device Identifier). Inclusion in EUDAMED confirms that their products are registered under EU medical device regulations, while listing in the FDA’s UDI system indicates compliance with U.S. requirements for traceability and transparency. This dual listing reflects the company’s focus on both European and American markets, ensuring their devices meet global regulatory standards.

MetaSystems Hard & Software GmbH’s emphasis on automated microscopy-based imaging solutions stems from the need for precision, efficiency, and reproducibility in diagnostic laboratories. Devices like karyotyping analysers and cell-image processors reduce human error in tasks such as chromosomal analysis, which is critical for conditions like genetic disorders or cancer diagnostics. By integrating software with microscopy, the company enables faster turnaround times while maintaining high accuracy, supporting clinical decision-making in complex medical scenarios.